SMi Group

Defence Exports is a major discussion area within the Defence arena and this conference will provide a fantastic insight into the Asia Export Controls and the future for Defence Exports in the region.

This conference will address and explore key issues such as current technologies, dose finding, adaptive clinical trials for rare disease medicine development, Bayesian adaptive designs and high-density biomarker data.

Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management that will address the challenges associated with obtaining an optimal portfolio of projects.

Now in its 14th year, this well established antibacterial event promises to be the perfect forum for networking and problem solving with senior industry executives from the pharmaceutical sector.

Imaging in Cancer Drug Development will offer an excellent arena to discuss challenges, compare techniques and gain valuable information on how this field is developing and how advances may be of benefit in the future.

SMi’s Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design. Key selected industry experts will provide you with timely and up-to-date information on many areas of drug design.

Social media is an area of communications in a state of continual evolution and flux and 2011 is proving to be a year of immense significance for the future of its application to the pharmaceutical and healthcare industry.

Building on the continual success of both our European and Asia Pacific events, this year's agenda will provide an unparalled opportunity for debate and problem solving of key challenges currently facing the parenteral market.

This Biomarkers Summit 2012 will provide a unique opportunity for debate and problem solving for key challenges facing the biomarkers fields as well as hearing from leading experts in this rapidly-evolving area.

SMi's first annual Defence Exports Asia conference is now less than 1 month away.